DOUBLE ALKYLATING AGENTS TREATMENT WITH IFOSFAMIDE (IFOS) AND CYCLOPHOSPHAMIDE (CYCLO) FOR RELAPSED PEDIATRIC SOLID TUMORS

被引：0

作者：

Epelman, Sidnei ^{[1
]}

Gorender, Ethel ^{[1
]}

Beaugrand, Annick ^{[1
]}

Meirelles, Priscilla ^{[1
]}

Oliveira, Renato ^{[1
]}

Melaragno, Renato ^{[1
]}

机构：

[1] Santa Marcelina Hosp, Sao Paulo, Brazil

来源：

PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1093 / 1093

页数：1

共 50 条

[31] Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients
Miano, Maurizio
Pistorio, Angela
Putti, Maria C.
Dufour, Carlo
Messina, Chiara
Barisone, Elena
Ziino, Ottavio
Parasole, Rosanna
Luciani, Matteo
Lo Nigro, Luca
De Rossi, Giulio
Varotto, Stefania
Bertorello, Nicoletta
Petruzziello, Fara
Calvillo, Michaela
Micalizzi, Concetta
LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1693 - 1698
[32] Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Tsuchida, Yoshiaki
Shitara, Toshiji
CURRENT PEDIATRIC REVIEWS, 2005, 1 (01) : 55 - 61
[33] INVESTIGATING THE HETEROGENEITY OF ALKYLATING AGENTS' EFFICACY AND TOXICITY BETWEEN GENDERS: A META-ANALYSIS OF RANDOMIZED TRIALS COMPARING CYCLOPHOSPHAMIDE AND IFOSFAMIDE (MAIAGE STUDY)
Fresneau, B.
Paulussen, M.
Hackshaw, A.
Hawkins, D. S.
Anderson, J. R.
Judson, I. R.
Dirksen, U.
Lewis, I. J.
Van den Berg, H.
Gaspar, N.
Gelderblom, H.
Whelan, J.
Boos, J.
Wheatley, K.
Pignon, J. P.
Le Deley, M. C.
Le Teuff, G.
PEDIATRIC BLOOD & CANCER, 2015, 62 : S167 - S167
[34] COMBINED ALKYLATING-AGENTS AND AUTOLOGOUS MARROW FOR THE TREATMENT OF SOLID TUMORS - PHASE-I - PHASE-II STUDIES
FREI, E
EDER, P
ANTMAN, K
CANCER INVESTIGATION, 1986, 4 (05) : 495 - 496
[35] IFOSFAMIDE ETOPOSIDE COMBINATION IN THE TREATMENT OF RECURRENT MALIGNANT SOLID TUMORS OF CHILDHOOD - A PEDIATRIC ONCOLOGY GROUP PHASE-II STUDY
KUNG, FH
PRATT, CB
VEGA, RA
JAFFE, N
STROTHER, D
SCHWENN, M
NITSCHKE, R
HOMANS, AC
HOLBROOK, CT
GOLEMBE, B
BERNSTEIN, M
KRISCHER, JP
CANCER, 1993, 71 (05) : 1898 - 1903
[36] EFFICACY AND SAFETY OF HIGH DOSE TOPOTECAN IN RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS
Miyamura, T.
Hashii, Y.
Yoshida, H.
Miyashita, E.
Uehara, S.
Oue, T.
Naka, N.
Morimoto, T.
Kagawa, N.
Ozono, K.
PEDIATRIC BLOOD & CANCER, 2013, 60 : 157 - 157
[37] Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
Pablo Gargallo
Jaime Font de Mora
Pablo Berlanga
Inés Calabria
Margarita Llavador
Laia Pedrola
Joaquín Panadero
Sandra Dolz
Ángel Zúñiga
Juan Silvestre Oltra
Paloma Escobar
Yania Yáñez
María José Aparisi
Marina Martinez-Matilla
Vanessa Segura
Carlos Esquembre
María Del Cañizo
María José Moreno
Catalina Márquez
Adela Cañete
Victoria Castel
Translational Medicine Communications, 4 (1)
[38] Phase I clinical and pharmacokinetic study of combination chemotherapy with topotecan and ifosfamide in patients with progressive or relapsed solid tumors
Schneider, CP
Merkel, U
Grübner, U
Kath, R
Höffken, K
Hoffmann, A
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (06) : 313 - 318
[39] ADOPTIVE CHEMOIMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED AND REFRACTORY SOLID TUMORS USING EXVIVO ACTIVATED MEMORY T-CELLS (AUTOLYMPHOCYTE THERAPY) AND CYCLOPHOSPHAMIDE
GOLD, JE
MALAMUD, SC
LAROSA, F
SEDER, R
OSBAND, ME
JOURNAL OF IMMUNOTHERAPY, 1993, 13 (03) : 213 - 221
[40] Phase I study of pegylated liposomal doxorubicin in combination with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory sarcoma and other malignant solid tumors.
Lu, Suying
Wang, Juan
Huang, Junting
Sun, Feifei
Zhu, Jia
Zhen, Zijun
Li, Hui
Sun, Xiaofei
Zhang, Yizhuo
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →